Substance Use Patterns and Safer Supply Preferences Among People Who Use Drugs in British Columbia

Report
by
Xavier, Jessica et al

Release Date

2023

Geography

Canada

Language of Resource

English

Full Text Available

Yes

Open Access / OK to Reproduce

No

Peer Reviewed

No

Objective

This report presents the findings of a multiyear study which aimed to understand the needs and preferences of people who use drugs from the illegal market and safer supply. To successfully separate people from the illegal supply, consultation with people who use drugs is paramount. These findings can inform policy recommendations for the effective design of safer supply models and programs that will be acceptable, desirable, and accessible to people who use drugs.

Findings/Key points

Includes 13 recommendations based on study findings: expand opioid and stimulant safer supply options to encourage acceptability and access and reduce barriers to current opioid, stimulant, and benzodiazepine safer supply options (Recommendations 1-4); expand safer supply mode of use options to encourage access and make overdose response services more equitable based on preferred mode of drug use (Recommendations 5-7); removing barriers associated with prescribed safer supply and prescriber hesitancy (Recommendations 8-10); improving access to safer supply across BC (Recommendations 11,12,13).

An infographic is also available.

Design/methods

The study comprised two components: the Harm Reduction Client Survey, and interviews and focus groups with people who use drugs. The Harm Reduction Client Survey was administered at harm reduction distribution sites across BC to assess peoples’ patterns of drug use, and peoples’ preferences for safer supply substances and modes of use. Interviews and focus groups were conducted to identify the strengths and challenges with safer supply as currently implemented in BC, and to better understand the preferences and expectations for future models of safer supply.

 

Keywords

Safer supply
About PWUD
Hesitancy of prescribers
Policy/Regulatory
Peer/PWLLE program involvement
Barriers and enablers